(Q33376498)
Statements
Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics (English)
Juan José Lahuerta
Joan Bladé
Adrián Alegre
Maria Victoria Mateos
Helgi Van de Velde
Anna Sureda
Pedro García-Sánchez
Carlos Herrero